EP Patent

EP4585229A2 — Means and method for preparing viral vectors and uses of same

Assigned to Novartis AG · Expires 2025-07-16 · 1y expired

What this patent protects

Methods for preparing and purifying viral particles, and compositions and uses comprising the same, are provided.

USPTO Abstract

Methods for preparing and purifying viral particles, and compositions and uses comprising the same, are provided.

Drugs covered by this patent

nusinersen-sodium (NUSINERSEN SODIUM)

Patent Metadata

Patent number: EP4585229A2
Jurisdiction: EP
Classification: —
Expires: 2025-07-16
Drug substance claim: No
Drug product claim: No
Assignee: Novartis AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.